We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

87 hedge funds and large institutions have $187M invested in BioSpecifics Technologies Corp. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

3% less funds holding

Funds holding: 90 → 87 (-3)

6% less capital invested

Capital invested by funds: $199M → $187M (-$11.3M)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

17% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 35

Holders
87
Holders Change
-3
Holders Change %
-3.33%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
29
Reduced
35
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$7.25M
2
NC
Northpointe Capital
Michigan
+$1.25M
3
ECP
Elk Creek Partners
Colorado
+$1.18M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$1.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$929K

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$2.64M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.85M
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$1.65M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.4M
5
ADEF
Adams Diversified Equity Fund
Maryland
-$619K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$1.95M +$170K +3,541 +9%
NI
27
Numeric Investors
Massachusetts
$1.89M -$2.64M -55,229 -58%
RA
28
Royce & Associates
New York
$1.84M +$5.6K +117 +0.3%
First Manhattan
29
First Manhattan
New York
$1.64M -$95.8K -2,000 -5%
CCM
30
Cadence Capital Management
Massachusetts
$1.38M +$68.6K +1,433 +5%
TCIM
31
TIAA CREF Investment Management
New York
$1.29M -$161K -3,365 -11%
American Century Companies
32
American Century Companies
Missouri
$1.19M -$232K -4,854 -16%
Deutsche Bank
33
Deutsche Bank
Germany
$1.18M -$200K -4,180 -14%
CAM
34
ClariVest Asset Management
California
$1.15M +$4.79K +100 +0.4%
ACM
35
Ativo Capital Management
Illinois
$1.05M +$144K +3,000 +15%
Morgan Stanley
36
Morgan Stanley
New York
$977K -$52.6K -1,099 -5%
AllianceBernstein
37
AllianceBernstein
Tennessee
$794K -$304K -6,350 -27%
SCA
38
Secor Capital Advisors
New York
$789K – – –
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$780K -$28.7K -600 -3%
IP
40
Isthmus Partners
Wisconsin
$779K +$11.9K +248 +2%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$744K -$91K -1,900 -11%
DCM
42
Dupont Capital Management
Delaware
$713K – – –
CEP
43
Chicago Equity Partners
Illinois
$644K +$29.2K +610 +5%
SO
44
STRS Ohio
Ohio
$604K – – –
CIBC Private Wealth Group
45
CIBC Private Wealth Group
Georgia
$534K +$550K +11,485 New
AL
46
AJO LP
Pennsylvania
$509K +$39.6K +827 +8%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$480K -$393K -8,201 -44%
TA
48
Teachers Advisors
New York
$470K – – –
PAM
49
Panagora Asset Management
Massachusetts
$443K -$438K -9,154 -49%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$423K -$45.3K -945 -9%
1
2
3 4

BSTC Hedge Fund Activity: Q3 2017 in Review

87 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2017, worth a combined $187M — down 5.7% from $199M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BSTC and 8 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 29 added.

The largest buyer was Stonepine Capital Management, adding an estimated $7.25M. The largest seller was Numeric Investors, cutting an estimated $2.64M.

  • 87 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2017, down from 90 in Q2 2017.
  • Funds reported $187M of BioSpecifics Technologies Corp. stock for Q3 2017, down 5.7% quarter-over-quarter.
  • 8 funds opened new BioSpecifics Technologies Corp. positions in Q3 2017 and 9 closed out, a net change of -1 holder.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2017 was Stonepine Capital Management, an estimated $7.25M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2017 was Numeric Investors, an estimated $2.64M sold.

Based on aggregated 13F filings for Q3 2017.